New bilateral agreements shift aid strategy and draw mixed reactions across the continent

The United States has introduced a new approach to global health cooperation through bilateral agreements with African countries. These deals, often structured as memorandums of understanding, replace or reshape earlier multilateral programs such as PEPFAR.

The agreements focus on five-year partnerships that require recipient governments to contribute funding, while US support gradually declines. They also expand US access to health data, biological samples, and disease surveillance systems. Officials describe this model as a move toward country ownership and shared responsibility.

Key Features of the Agreements

Under these arrangements, countries receive financial and technical support for programs targeting diseases such as HIV and malaria. In return, they commit to co-financing health services and sharing data that can support global outbreak monitoring.

The structure aims to reduce long-term dependence on external aid. At the same time, it introduces new expectations around transparency, data access, and collaboration with US agencies and companies.

Concerns Over Data and Sovereignty

The agreements have triggered debate in several countries. Critics point to provisions that allow expanded access to sensitive health data and biological materials. Some governments and civil society groups argue that these terms could weaken national control over data and raise privacy concerns for citizens.

There are also questions about whether countries will benefit equally from any research or medical advances that result from shared data. Concerns about fairness and reciprocity have shaped negotiations in multiple states.

Link to Critical Minerals

Another point of tension involves reports that health agreements may connect to access to critical minerals such as copper, cobalt, and lithium. These resources play a key role in global supply chains and technology production.

Some officials and analysts argue that the US is using health partnerships to strengthen its position in strategic sectors, especially in competition with China. This has raised concerns about whether development aid is being tied to commercial or geopolitical interests.

Zambia Pushes Back

Zambia has emerged as a leading voice of resistance. On May 4, 2026, Foreign Minister Mulambo Haimbe outlined the government’s concerns over a proposed agreement valued at up to 2 billion dollars.

Zambian officials objected to data-sharing terms they believe could compromise citizens’ privacy. They also raised concerns about a separate minerals agreement that would grant preferential access to US companies.

According to Zambia, progress on the health deal appeared tied to the minerals negotiations. The government insists that each agreement should stand on its own. Talks have slowed, raising concerns about funding gaps for HIV treatment programs that support over one million people.

Countries That Have Signed

Several African nations have accepted versions of these agreements, including Kenya, Uganda, Rwanda, Nigeria, and Ethiopia. Others include Mozambique, Cameroon, and the Democratic Republic of the Congo.

In some cases, these agreements have moved forward without public disputes over minerals. Still, concerns about data access and funding structures have sparked legal and political challenges, including court action in Kenya.

Countries That Have Rejected or Delayed

A number of countries have declined or paused negotiations. Zimbabwe rejected proposals over data-sharing concerns. Ghana also declined recent terms and is seeking revisions. South Africa has not signed and faces separate tensions affecting aid flows.

Other countries have remained cautious or absent from early agreements, reflecting a broader hesitation about the new model.

A More Transactional Approach

The evolving strategy reflects a shift in how the US approaches foreign aid. Supporters argue that it promotes self-reliance and aligns assistance with mutual interests. Critics view it as a more transactional system that places additional pressure on recipient countries.

Outcomes vary depending on each country’s economic position, resource base, and negotiating power. Nations with valuable minerals or larger markets may face different terms compared to smaller economies.

As more details of these agreements emerge, debates over fairness, sovereignty, and long-term impact are likely to continue. Governments must weigh immediate health funding needs against broader concerns about data control and economic independence.

The direction each country takes will shape not only its health sector but also its role in global partnerships that extend beyond aid.

Also Read

China Emerges as a Global Medical Tourism Powerhouse with Rapid Growth and Advanced Care

What Happens When You Stop Ozempic or Mounjaro? New Research Explains the Effects